There’s another Pappas working at Pappas Capital, but the venture capital firm is quick to point out that Nick Pappas is “no relation” to the firm’s founder Art Pappas.
Read More
North Carolina Biotechnology Center board member Karen LeVert is among three women receiving the 2022 Women in Agribusiness Demeter Award of Excellence, which recognizes those who have achieved excellence in their field or demonstrated an extraordinary contribution to the agribusiness industry.
Read More
Two Triangle firms will collaborate to ensure that North Carolina is a leader in agricultural technology, or AgTech. SAS and Pappas Capital announced a partnership that aims to equip AgTech startups with data and analytics tools, guidance, and expertise.
Read More
Drug giant Merck is paying $2.75 billion in cash for a biotech startup, VelosBio, which had landed two investments from Pappas Capital. And the deal is a big one for Pappas.
Read More
Like other African American business leaders in the Triangle, she is calling for change in the wake of George Floyd’s death at the hands of police in May.
Read More
Karen LeVert will help expand the firm’s Specialized Fund Management business – which handles customized investments for third parties – by focusing on opportunities in agricultural and related technologies, the company said.
Read More
A new clinical-stage biotechnology company formed by Triangle-based Pappas Capital will be led by a partner at Pappas Ventures and will receive funding from Pappas Capital as well as Novo Holdings.
Read More
Alex Arfaei, a former managing director with BMO Capital Markets, has joined an expanding Pappas Ventures as a partner
Read More
Pappas Ventures’ founder Art Pappas is not retiring but changes are being made at the venture capital firm he launched 25 years ago.
Read More
